Minireviews
Copyright ©The Author(s) 2019.
World J Gastroenterol. Aug 21, 2019; 25(31): 4405-4413
Published online Aug 21, 2019. doi: 10.3748/wjg.v25.i31.4405
Table 3 Comparison of performance between pancreatic cyst guidelines
StudiesComparisonsOutcomeResultPerformance
Sighinolfi et al[21], 2017Fukouka, AGA, and Sendai Criteria1Pancreatic Cyst with invasive cancerAGA ROC 0.76, Fukouka ROC 0.78, Sendai ROC 0.65 (P < 0.001)AGA and Fukuoka guidelines with higher diagnostic accuracy for neoplastic cysts compared to Sendai
Xu et al[20], 2017AGA, Fukouka, and American College of Radiology1Advanced neoplasia (HGD or cancer) in resected pancreatic cysts(Sen, Spec, PPV, NPV) AGA; 7.3%, 88.2%, 10%, and 84.1% Fukouka: 73.2%, 45.6%, 19.5%, 90.4% ACR: 53.7%, 61%, 19.8%, and 88%AGA with higher specificity, but lower sensitivity than Fukuoka and ACR
Ma et al[22], 2016AGA and Fukouka2Advanced neoplasia (HGD or cancer) in resected pancreatic cystsFukouka: 28.2%, 95.8%, 74.1%, 75.9% AGA: 35.2.%, 94%, 71.4%, 77.5%No significant difference between the two guidelines
Singhi et al, 2016AGAAdvanced neoplasia (HGD or cancer)AGA: 62%, 79%, 57%, 82%Low accuracy of AGA guidelines and continued surveillance of benign lesions (i.e., SCAs)
Lekkerkerker et al[23], 2017Fukuoka, AGA, European GuidelinesAdvanced neoplasia (in patients with suspected IPMN)Accuracy Fukuoka: 54% AGA: 59% European: 53%AGA guidelines would have rec’d against surgery in most patients with benign lesions and would have missed significantly more HGD/CA